Novo Nordisk A/S (NYSE:NVO)

51.66
Delayed Data
As of Aug 16
 +1.37 / +2.72%
Today’s Change
41.23
Today|||52-Week Range
52.83
+12.13%
Year-to-Date
NVO Regular Dividend: NVO began trading ex-dividend on 08/16/19. A $0.4494 dividend will be paid to shareholders of record as of 08/19/19.
Top Stock Reports for Cisco, Medtronic & Novo Nordisk
Aug 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients
Aug 09 / Zacks.com - Paid Partner Content
Novo Nordisk Waits for Its Next Launch
Aug 15 / MotleyFool.com - Paid Partner Content
Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates
Aug 09 / Zacks.com - Paid Partner Content
Why Earnings Season Could Be Great for Novo Nordisk (NVO)
Aug 12 / Zacks.com - Paid Partner Content
NVS vs. NVO: Which Stock Should Value Investors Buy Now?
Aug 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close50.29
Today’s open51.30
Day’s range51.11 - 51.68
Volume1,688,083
Average volume (3 months)1,478,869
Market cap$93.3B
Data as of 6:30pm ET, 08/16/2019

Growth & Valuation

Earnings growth (last year)+8.07%
Earnings growth (this year)+0.93%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+4.51%
P/E ratio22.2
Price/Sales6.31
Price/Book15.56

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+1.45+2.30%
GSKGlaxoSmithKline+0.23+0.58%
SNYSanofi+0.37+0.89%
LLYEli Lilly and Co+0.29+0.26%
Data as of 6:30pm ET, 08/16/2019

Financials

Next reporting dateNovember 1, 2019
EPS forecast (this quarter)$0.61
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts